2024-11-18 17:44:09
Shanghai Cellular Biopharmaceutical Group presents first data from Phase I trial evaluating a novel CAR-T in advanced liver cancer at AACR Annual Meeting
Corporate/ 2023-07-24
Shanghai Cellular Biopharmaceutical Grou...

Promising anti-tumor activity reported for C-CAR031,a novel Glypican 3 (GPC3)-targeting cell therapy designed by AstraZeneca

Bridge Biotherapeutics Announces First Patient Dosed in its Phase 2a Clinical Trial of BBT-877, a Potent Autotaxin Inhibitor for the Treatment of Idiopathic Pulmonary Fibrosis
Corporate/ 2023-07-24
Bridge Biotherapeutics Announces First P...

SEONGNAM,South Korea and CAMBRIDGE,Mass.,April 13,2023-- Bridge Biotherapeutics (KQ288330),a clinical-stage biotech company based in South K...

CUSMail

CusMail provide the Latest News , Business and Technology News Release service. Most of our news is paid for distribution to meet global marketing needs. We can provide you with global market support.

© CUSMAIL. All Rights Reserved. Operate by Paid Release